Table I.

Detailed information of the antibodies utilized in this study.

Antibody	Company (cat. no.)	Dilution
Hypoxia inducible factor 1 α	Abcam (ab51608)	1:1,000 (western blotting); 1:500
		(immunocytochemical); 1:50
		(co-immunoprecipitation)
Microphthalmia-associated transcription	Proteintech Group, Inc.	1:1,000 (western blotting);
factor	(13092-1-AP)	1:1,000 (immunocytochemical)
von Hippel-Lindau disease tumor suppressor	Proteintech Group, Inc.	1:1,000 (western blotting);
	(24756-1-AP)	1:1,000 (immunocytochemical)
Protein inhibitor of activated STAT protein 4	Proteintech Group, Inc.	1:1,000 (western blotting);
	(14242-1-AP)	1:1,000 (immunocytochemical)
Small ubiquitin-like modifier 1	CST (4930S)	1:1,000 (western blotting)
Small ubiquitin-like modifier 23	CST (4971T)	1:1,000 (western blotting)
β-actin	OriGene Technologies,	1:3,000 (western blotting)
	Inc. (TA-09)
GAPDH	Affinity (AF7021)	1:3,000 (western blotting)
H3	Affinity (BF9211)	1:1,000 (western blotting)
Anti-Mouse IgG HRP-linked	CST (7074F)	1:5,000 (western blotting)
Anti-Rabbit IgG HRP-linked	CST (7076F)	1:5,000 (western blotting)